Biophage Pharma
Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).
| Address: | 6100 Royalmount |
| City: | Montreal |
| State/Province: | Quebec |
| Postcode: | H4P 2R2 |
| Country/Region: | Canada |
|
